A joint investigation withMcClatchy DCProPublica

How Prepared is the U.S. For a Bioterrorism Attack?


In mid-September 2001, a retired Air Force colonel successfully smuggled an anthrax-like substance into the White House. This warning could have sparked a robust new plan to prevent or respond to bioterrorism.

It didn’t, at least according Wil S. Hylton in his new New York Times Magazine feature about the lack of progress the U.S. has made since the post-9/11 anthrax attacks in 2001. Some key points from Hylton’s piece:

+ The anthrax vaccine the government has been stockpiling is old, has side effects and has never been approved for use in children.

+ Attempts to develop new vaccines — for anthrax, in particular — have been mired by funding problems, congressional lobbying and disagreements over whether this type of of vaccine should be prioritized at all.

+ Two recent reportsĀ on the U.S. program from two biodefense review boards were “scathing”: One described the program as lacking urgency, coherence, prioritization and synchronization; the other gave the U.S. an “F” for biodefense.

+ There is a lack of leadership at the top: While both the Clinton and George W. Bush administrations had some type of a “biodefense czar,” the job has gone unfilled in the Obama administration. Says Randall Larsen, the White House smuggler (and national security expert) mentioned earlier:

Today, there are more than two dozen Senate-confirmed individuals with some responsibility for biodefense. Not one person has it for a full-time job, and no one is in charge.

Read the article in full here. And if you missed it, you can watch our recent film The Anthrax Files, which reveals holes in the feds’ case against anthrax attack suspect Dr. Bruce Ivins, here.

blog comments powered by Disqus

In order to foster a civil and literate discussion that respects all participants, FRONTLINE has the following guidelines for commentary. By submitting comments here, you are consenting to these rules:

Readers' comments that include profanity, obscenity, personal attacks, harassment, or are defamatory, sexist, racist, violate a third party's right to privacy, or are otherwise inappropriate, will be removed. Entries that are unsigned or are "signed" by someone other than the actual author will be removed. We reserve the right to not post comments that are more than 400 words. We will take steps to block users who repeatedly violate our commenting rules, terms of use, or privacy policies. You are fully responsible for your comments.



The Fight for YemenApril 7th


Frontline Journalism Fund

Supporting Investigative Reporting

Funding for FRONTLINE is provided through the support of PBS viewers and by the Corporation for Public Broadcasting. Major funding for FRONTLINE is provided by John D. and Catherine T. MacArthur Foundation. Additional funding is provided by the Park Foundation, the Ford Foundation, Wyncote Foundation, and the FRONTLINE Journalism Fund with major support from Jon and Jo Ann Hagler on behalf of the Jon L. Hagler Foundation.

Privacy Policy   Journalistic Guidelines   PBS Privacy Policy   PBS Terms of Use   Corporate Sponsorship
FRONTLINE is a registered trademark of WGBH Educational Foundation.
Web Site Copyright ©1995-2015 WGBH Educational Foundation
PBS is a 501(c)(3) not-for-profit organization.